Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

Please use this identifier to cite or link to this item: https://doi.org/10.1097/JTO.0b013e3181dd1386

Title:	Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
Authors:	Yeo, W.-L. Lau, M.W. Warner, J.L. Bodio, K. Huberman, M.S. Tenen, D.G. Kobayashi, S. Costa, D.B. Riely, G.J. Kris, M.G. Yeap, B.Y. Pao, W.
Keywords:	EGFR Epidermal growth factor receptor Erlotinib Exon 19 deletions Gefitinib L858R Lung cancer Mutation Non-small cell lung cancer Tyrosine kinase inhibitors
Issue Date:	2010
Citation:	Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W. (2010). Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. Journal of Thoracic Oncology 5 (7) : 1048-1053. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e3181dd1386
Source Title:	Journal of Thoracic Oncology
URI:	http://scholarbank.nus.edu.sg/handle/10635/27135
ISSN:	15560864 15561380
DOI:	10.1097/JTO.0b013e3181dd1386
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check